SEP 24, 2018 10:01 PM PDT

Protein Serves as a Potential Drug Target

WRITTEN BY: Nouran Amin

Image via Phys.org

Researchers at Van Andel Research Institute (VARI) have shown an atomic-level structure of a protein that may serve as a future drug target for conditions like Alzheimer's disease and bipolar disorder.

The protein, known as TRPM2, was found throughout the body to integrally be involved in body temperature regulation, immune response mediation, and governing the programmed death of cells (apoptosis).

TRPM2 belongs to the TRP superfamily of proteins that work to mediate responses to sensory stimuli, inclduing pain, pressure, vision, temperature and taste.

"TRPM2 is absolutely critical for healthy function but, until today, we were missing key insights into its structure and mechanism of action," says Juan Du, Ph.D., an assistant professor at VARI. "It is our hope that these findings will act as a schematic for designing better and desperately needed medications for a host of neurological conditions." It is now the first protein to be pictured at the atomic level.

Image via Drug Target Review

The images of TRPM2 on the atomic level have illustrated a “bell-like structure, with a transmembrane domain region on the bell's shoulder and an expanded NUDT9-H domain on the bell's lip”. Images also revela the bindg site for ADPR, the messenger molecule associated with oxidative stress and metabolism. "Although we have known for some time that TRPM2 is a vital component of many biological processes and a possible drug target, we didn't know exactly what it looked like or how it worked," said Wei Lü, Ph.D., an assistant professor at VARI and co-senior author. "Today's findings change that, and go a long way toward a more comprehensive understanding of these incredibly important molecules."

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
OCT 19, 2019
Drug Discovery & Development
OCT 19, 2019
Understanding The Anti-Malarial Drug Primaquine (PQ)
Scientists at the Liverpool School of Tropical Medicine (LSTM) have advanced their experiments to understand the mode of action for the anti-malarial drug ...
OCT 19, 2019
Drug Discovery & Development
OCT 19, 2019
Novel Therapy Shows Promise for Acute Migraines
In a study published in The New England Journal of Medicine, a novel drug, by the name of rimegepant, was found to eliminate pain and reduce characteristic...
OCT 19, 2019
Drug Discovery & Development
OCT 19, 2019
Aspirin Usage Improves Liver Function After Embolization Treatment
Aspirin usage has been under scrutiny in recent research. But now, studies are bringing aspirin therapy in renewed light with its association in improving ...
OCT 19, 2019
Genetics & Genomics
OCT 19, 2019
Non-Invasive Gene Therapy Holds Promise for Treating Blindness
Researchers at John Hopkins Medicine have found a way to deliver sight-saving gene therapy to the retina. Having already shown success in treating rates, p...
OCT 19, 2019
Drug Discovery & Development
OCT 19, 2019
Evolutionary-Busting Cancer Drug
Researchers at the Institute of Cancer Research in London have discovered that a new type of drug that blocks treatment in cancers. The drug works by inhib...
OCT 19, 2019
Drug Discovery & Development
OCT 19, 2019
Nanomesh Development Advances Drug Delivery's Fight Against Antibiotic-Resistance
As concern over medication-resistant bacteria grows, researchers at Flinders University have now fabricated nanomeshes as an effective drug delivery method...
Loading Comments...